BridgeMD
New treatment option for Spondylolysis
Official title Bone Stimulator for Spondylolysis
ClinicalTrials.gov ID: NCT06666608
What this study is testing
- What it's testing
- This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide valuable insights into the role of bone stimulation therapy as a potential treatment modality for this challenging condition.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 40
You may be able to join if
- Patients between the ages of 16 to 40 years of age diagnosed with symptomatic spondylolysis by one of the investigators
- Patients who plan to attend prescribed physical therapy
- Patients who participate in a regular sport whether that be professional, collegiate or recreational
You likely can't join if
- Any condition which in the investigator's opinion, would interfere with the subject's ability to comply with study instructions
- Patients with contraindications to bone stimulator therapy
- Patients with pacemaker and implantable cardioverter defibrillator
- Patients with previous spine surgery
- Patients with metabolic bone conditions
- Patients who use nicotine products
See the full eligibility criteria
- Patients between the ages of 16 to 40 years of age diagnosed with symptomatic spondylolysis by one of the investigators
- Patients who plan to attend prescribed physical therapy
- Patients who participate in a regular sport whether that be professional, collegiate or recreational
- Any condition which in the investigator's opinion, would interfere with the subject's ability to comply with study instructions
- Patients with contraindications to bone stimulator therapy
- Patients with pacemaker and implantable cardioverter defibrillator
- Patients with previous spine surgery
- Patients with metabolic bone conditions
- Patients who use nicotine products
- Vulnerable populations
- Non-English speaking services
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.